Video

Aurion BioTech presents cell therapy findings with published clinical data

Author(s):

Kassi Jackson
Conferences|ASCRS

Greg Kunst, president and CEO of Aurion BioTech, shares a company update on endothelial cell therapy trials, clinical plans and upcoming data.

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
Related Content
RhyGaze secures Series A financing of $86 million to further novel gene therapy
January 15th 2025

RhyGaze secures Series A financing of $86 million to further novel gene therapy

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

European Medicines Agency to assess semaglutide for link to NAION
January 3rd 2025

European Medicines Agency to assess semaglutide for link to NAION

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

©Anamarila - stock.adobe.com
December 27th 2024

Alert: Alcon voluntarily recalls Systane Ultra PF lot due to potential fungal contamination

Targeting IL-6 inflammation: A promising frontier in treating thyroid eye disease
December 26th 2024

Targeting IL-6 inflammation: A promising frontier in treating thyroid eye disease

© 2025 MJH Life Sciences

All rights reserved.